A high index of suspicion: The key to an early diagnosis of Wilson's disease in childhood

Journal of Pediatric Gastroenterology and Nutrition

Volumn 28, Issue 2, 1999, Pages 186-190

  Sánchez Albisua, Icíar ^a   Garde, Teresa ^a   Hierro, Loreto ^a   Camarena, Carmen ^a   Frauca, Esteban ^a   De La Vega, Angela ^a   Díaz, María Carmen ^a   Larrauri, Javier ^a   Jara, Paloma ^a  

^a HOSPITAL INFANTIL LA PAZ   (Spain)

Author keywords

Child; Hepatolenticular degeneration; Liver transplantation; Penicillamine

Indexed keywords

PENICILLAMINE;

ADOLESCENT; ARTICLE; CHILD; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; COPPER METABOLISM; DRUG TOLERABILITY; EARLY DIAGNOSIS; FEMALE; HISTOLOGY; HUMAN; LABORATORY DIAGNOSIS; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; WILSON DISEASE;

ADOLESCENT; CERULOPLASMIN; CHELATING AGENTS; CHILD; CHILD, PRESCHOOL; COPPER; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; PENICILLAMINE; PROGNOSIS; RETROSPECTIVE STUDIES; SPAIN;

EID: 0344689844     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199902000-00018     Document Type: Article

References (38)

1. Sokol RJ. Wilson's disease and Indian childhood cirrhosis. In: Suchy FJ, ed. Liver disease in children. St Louis: Mosby, 1994: 747-72.
2. Dobyns WB, Goldstein NP, Gordon H. Clinical spectrum of Wilson's disease (hepatolenticular degeneration) Mayo Clin Proc 1979;54:35-42.
3. Ghiagheddu A, Demelia L, Puggioni G, et al. Epidemiologic study of hepatolenticular degeneration (Wilson's disease) in Sardinia (1902-1983). Acta Neurol Scand 1985;72:43-55.
4. al Molfleh IA, al Hashed RS, Ayoola EA, Sabah DM, Hafeez MA. Hepatic manifestations of Wilson's disease: Frequency and pattern in Saudi patients. Trop Gastroenterol 1993;14:91-8.
5. Stremmel W. Response to: Brown BW, Palmier JA. Wilson disease: Penicillamine therapy and late presentation (letter). Ann Intern Med 1992;116:424-5.
6. Mohamed R, Tan CT, Wong NW. Wilson's disease: A review of cases at University Hospital, Kuala Lumpur. Med J Malaysia 1994; 49:49-52.
7. Park RH, McCabe P, Fell GS, Russell RI. Wilson's disease in Scotland. Gut 1991:32:1541-5.
8. Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreutzpaintner G, Strohmeyer G. Wilson disease: Clinical presentation, treatment and survival. Ann Intern Med 1991;115:720-6.
9. Lahey ME, Behar M, Viteri F, Scrimshaw NS. Value for copper, iron and iron-binding capacity in the serum in kwashiorkor. Pediatrics 1958;22:72-9.
10. McCullough AJ, Fleming CR, Thistle JL, et al. Diagnosis of Wilson's disease presenting as fulminant hepatitis. Gastroenterology 1983;84:161-7.
11. Perman JA, Werlin SL, Grand RJ, et al. Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson's disease in children. J Pediatr 1979;94:564-8.
12. Scheinberg IH, Cook CD, Murphy JA. The concentration of copper and ceruloplasmin in maternal and infant plasma at delivery. J Clin Invest 1954;33:963.
13. Edwards CQ, Williams DM, Cartwright GE. Hereditary hypoceruloplasminemia. Clin Genet 1979;15:311-6.
14. Gibbs K, Walshe JM. A study of the caeruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups. Q J Med 1979;48:447-63.
15. Frommer DJ. Direct measurement of serum non-ceruloplasmin copper concentrations in liver disease. Digestion 1981;21:169-78.
16. DaCosta CM, Baldwin D, Portmann B, et al. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology 1992;15:609-15.
17. Frommer DJ. Urinary copper excretion and hepatic copper concentration in liver disease. Digestion 1981;21:169-78.
18. Yarze JC, Martin P, Muñoz SJ, Friedman LS. Wilson's disease: Current status. Am J Med 1992;92:643-54.
19. Tauxe WN, Goldstein NP, Randall LV, et al. Radiocopper studies in patients with Wilson's disease and their relatives. Am J Med 1966;41:375-80.
20. Sternlieb I, Scheinberg IH. The role of radiocopper in the diagnosis of Wilson disease. Gastroenterology 1979;77:138-42.
21. Ferenci P, Gilliam TC, Gitlin JD, et al. An international symposium on Wilson's and Menkes' disease. Hepatology 1996;24: 952-8.
22. Petrukhin K, Fischer SG, Piratsu M, et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet 1993:5:338-43.
23. Bull PC, Thomas GR, Mommens JM, et al. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993;5:327-37.
24. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 1993;197:271-7.
25. Sternlieb I. The outlook for the diagnosis of Wilson's disease. J Hepatol 1993;17:263-4.
26. Sternlieb I, Scheinberg IH. Prevention of Wilson's disease in asymptomatic patients. N Engl J Med 1968;278:352-9.
27. Sallie R, Katsiyiannakis L, Baldwin D, et al. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure. Hepatology 1992;16:1206-11.
28. Schilsky ML, Scheinberg H, Sternlieb I. Prognosis of wilsonian chronic active hepatitis. Gastroenterology 1991;100:762-7.
29. Berman DH, Leventhal RI, Gavaler JS, et al. Clinical differentiation of fulminant wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991;100:1129-34.
30. Chan CY, Baker A. Penicillamine hypersensitivity: Successful desensitization of a patient with severe hepatic Wilson's disease. Am J Gastroenterol 1994;89:442-3.
31. Farinati F, Cardin R, Mestriner C, Sturniolo GC, Naccarato R. Mechanisms of penicillamine and zinc in the treatment of Wilson's disease (letter). Am J Gastroenterol 1995;90:2264-5.
32. Mason J, McQuaid A, Pheiffer H. Can Wilson disease patients be decoppered (letter)? Lancet 1989;i:1455.
33. Scheinberg IH, Sternlieb I, Schilsky M, Stocken RJ. Penicillamine may detoxify copper in Wilson's disease (letter). Lancet 1987;ii:95.
34. Yarze JC. The mechanisms of penicillamine, trientine and zinc in the treatment of Wilson's disease. Am J Gastroenterol 1995;90: 1026.
35. Walshe JM. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Q J Med 1973;42:441-52.
36. Brewer GJ. Practical recommendations and new therapies for Wilson's disease. Drugs 1995;50:240-8.
37. Nazer H, Ede RJ, Mowat AP, Williams R. Wilson's disease: Clinical presentation and use of prognostic index. Gut 1986;27:1377-1381.
38. Diaz J, Acosta F, Cañizares F, et al. Does orthotopic liver transplantation normalize copper metabolism in patients with Wilson's disease? Transplant Proc 1995;27:2306.